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Abstract
The curative effects of Chinese herbal compounds
result from the coordination of numerous natural
compounds. We aimed to review the mechanism of
action of Traditional Chinese Medicine (TCM) com-
pounds (TCMC), explore the rationality of formula-
tion theory and synergistic effects in TCM com-
pounds, and analyze the effectiveness of drug com-
patibility of TCMC in molecular biology. This litera-
ture review covers the mechanisms of the anti-tu-
mor effects of compounds, and their synergistic an-
titumor mechanisms. We aim to provide reference
for the effective development and use of natural re-
sources and the organic combination of TCM and
modern medicine using molecular biology.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Traditional Chinese Medicine (TCM) treatment for tu-
mors uses multiple components to target multiple sites
and optimal efficacy. TCM combines medicines accord-
ing to their natural odor, meridian tropism, and rela-
tionship of monarch, minister, assistant, and guide
herbs. The combination of herbs has a network adjust-
ment effect that is not present in Western Medicine.
The modernization of TCM focuses on the study of ac-
tive ingredients in Chinese medicines. This has led to
the discovery of a variety of compounds, including arte-
misinin and tanshinone, which are effectively applied
in clinic. The effectiveness of TCM does not lie in one
or a few herbs, but in the entire prescription. The toxic-
ity of some Chinese medicine compounds can be abat-
ed or gradually offset with extra herbs, but the overall
efficacy is strengthened.1 In this review, we summarized
the mechanisms of the anti-tumor effects of effective
compounds from TCM, and their synergistic antitu-
mor mechanisms.
RESEARCH PROGRESS ON
MOLECULARMECHANISMS OF
ANTI-TUMOR EFFECTS OFTCM
COMPOUNDS
The curative effects of TCM compounds result from
the coordination of natural compounds. For example,
Zhou's Kejinyan compound is clinically effective for
lung cancer. Anti-lung cancer recipes are composed of
four types of functional drugs and aim to clear phlegm,
dispel turbidity, promote the blood flow, remove stasis,
regulate Qi, descend adverse flow of Qi, and tonify Qi
100
JTCM |www. journaltcm. com February 15, 2014 |Volume 34 | Issue 1 |
Zhou J et al. / Review
and nourish Yin.2 By screening the prescription with
high throughput screening, we get more than 20 com-
pounds which have cytotoxic effects on non-small cell
lung cancer, including quercetin, isoliquiritigenin, cate-
chin compounds, ophiopogonin, ginsenosides, and
bibenzyl compounds.
Quercetin cytostatic and pro-apoptotic effect on
tumor cells
Quercetin and its derivatives are flavonoids found in
plants, and are present in flowers, leaf, and fruit. They
have many pharmacological effects including as an anti-
oxidant, anti-inflammatory, hypotensive, and anti-coag-
ulant. They also have cancer, aging, mutagenic, and
atherosclerosis preventive activities.3
Jin et al 4 found that quercetin had an obvious inhibito-
ry effect on the proliferation of A549 human lung ade-
nocarcinoma cells and transplanted mouse Lewis's lung
carcinoma cells. According to immunohistochemistry,
quercetin could obviously lower proliferating cell nucle-
us antigen (PCNA) expression levels. By inhibiting the
expression of PCNA, quercetin could reduce the activi-
ty of DNA polymerase D, and inhibit the synthesis of
DNA in tumor cells. They also found that quercetin in-
duced apoptosis of mouse melanoma Cloudman S91
cells in a dose-dependent manner.5 The mechanism
was via inhibition of the expression of gene protein
p53 and BC-l2. This blocked the cell cycle progression
from G1 to S phase, and caused the cells in G1 to accu-
mulate, which lowered the PCNA expression level.
Lower PCNA inhibited DNA synthesis in the S phase,
and inhibited the proliferation of tumor cells.
In addition, Cipka et al 6 reported that quercetin could
strengthen the apoptosis effect of cisplatin on human
leukemia HL-60 and rat leukemia L1210 cells after
joint administration.
Cytostatic and pro-apoptotic effects of
isoliquiritigenin (ISL) on tumor cells
ISL is an isoflavonoid found in licorice, Guangguogan-
cao (Radix Glycyrrhizae Glabrae), Zhangguogancao (Ra-
dix Glycyrrhizae Inflatae) dry root and rhizome,
Huangqi (Radix Astragali Mongolici) root,7 and Da-
huangjing (Rhizoma Polygonati Kingiani) root.8 It has
antitumor, anti-oxidative, and anti-inflammatory ef-
fects. It also can expand the arteries and protect the
heart and brain.9
Kanazawa et al 10 investigated the influence of ISL on
the gene expression of cell proliferation, cell cycle con-
trol, and cell cycle regulation. They also studied the an-
titumor activity of ISL in vitro on prostatic cancer, us-
ing the prostate cancer cell lines DU145 and LNCaP.
They found that ISL had significant dose- and time-in-
hibitory effects on prostatic cancer cell strains. Fluores-
cence activated cell-sorting analysis showed that ISL in-
duced cell cycle block in the S and G2/M phases, and
enhanced the expression of GADD153 protein mRNA.
Hsu et al 11,12 found that ISL could inhibit the prolifera-
tion of human non-small cell lung cancer A549 cells.
ISL could not only inhibit the proliferation of A549
cells, but also induce cell apoptosis and block cell cycle
progression in G1. ISL realized the anti-proliferative ef-
fect on lung cancer cells A549 through the p53 gene
and the Fas/FasL cell apoptosis system. ISL could also
inhibit the proliferation of human hepatocellular carci-
noma cells. With an IC50 of 10.51 μg/mL, ISL can in-
hibit cell growth, and lead cells to programmed death
by activating caspases. ISL can also inhibit the expres-
sions of Bcl-xL and C-IAP1/2 proteins, and reduce the
levels of NF-κB and its activities in the nucleus. Hsu et
al also found that ISL could lead to a rise in p53 gene
expression, and incrementally regulate p21/WAF1, Fas/
APO-1 receptor, Fas ligand, Bax, and NOXA.
Cytostatic and pro-apoptotic effects of tea
polyphenols and their catechins on tumor cells
Catechins are flavonoids and anthocyans of flavonoid
glycosides. They are widely distributed in plants such
as tealeaves, hawthorn, wild strawberries, cocoa fruit,
and grape seeds. Catechins have biological activities
such as anti-oxidative, anti-cancer, anti-inflammatory,
anti-aging, and anti-mutation effects, and liver func-
tion improvement.13
Gupta et al 14 found that epigallocatechin gallate
(EGCG) could induce cell cycle block and apoptosis of
prostate cancer cells. It could increase the expression of
WAF1/p21, KIP1/p21, INK4a/p16, and INK4c/p18
protein in a dose- and time-dependent manner, lower
the expressions of cyclin D1, cyclin E, Cdk2, Cdk4,
and Cdk, except for cyclin D2. It could also increase
the combination of cyclin E, WAF1/p21, and KIP1/
p21, decrease the combination of cyclin E and Cdk2,
and inhibit the adjustment of cyclin Cdk complexes in
the G0/G1 phase.
Sun et al 15 investigated the influence and mechanism
of EGCG on lung cancer cell proliferation. The results
showed that EGCG could significantly inhibit the prolif-
eration of A549 cells. After administration of 60 mg/L
EGCG, Hoechst staining showed obvious chromatin
condensation, and dense or fragmental hyperchromatic
cell apoptosis. The apoptotic rate was much higher
than that of the control group. The survivin expression
in many lung cancer tissues was the strongest apoptosis
inhibiting factor found so far. Western blot showed
that survivin protein expression in the treatment group
was significantly inhibited, which indicated that
EGCG suppressed the proliferation of lung cancer cells
by inhibiting survivin expression and promoting lung
cancer cell apoptosis.
Inhibition effect of ophiopogonin on tumor cells
Ophiopogonin is a steroid saponin, and mainly comes
from the liliaceous plants Tumaidong (Radix Liriopes
Spicatae), Shanmaidong (Radix Liriopes Proliferae),
Duantingshanmaidong (Radix Liriopes Musacarli), and
Kuoyeshanmaidong (Radix Liriopes Platyphyllae). Ophi-
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opogonin has extensive pharmacological activities such
as those against myocardial ischemia and myocardial in-
farction, arrhythmias, and tumors.16
Zhang et al 17 studied the mechanism of ophiopogonin
by testing the adhesion and invasion effect of Duant-
ingshanmaidong (Radix Liriopes Musacarli) saponins
DT-13 on lung cancer A549 cells and their effects on
the expression and activity of matrix metalloproteinas-
es. They found that Ophiopogon DT-13 at 10 and
30 μM could significantly inhibit the adhesion and in-
vasion of A549 cells, and the expression of matrix me-
talloproteinases-2/9 in A549 cells. Chen et al 18 showed
that ophiopogonin B had different degrees of inhibi-
tion on non-small cell lung cancer cells H157 and
H460. Flow cytometry showed that the cells were
blocked in the G0/G1 phase. Moreover, ophiopogonin
B cells could induce autophagy, transduce the path-
ways for mTOR signals, and inhibit phosphorylated
Akt (Ser473 and Thr308 loci).
Inhibition and pro-apoptotic effect of ginsenoside
Rg3 on hormone dependent tumor cells
Ginsenoside Rg3 is a tetracyclic triterpenoid saponin,
which is found in Renshen (Radix Ginseng) root. There
are two structural isomers, 20(R)-ginsenoside and 20
(S)-ginsenoside. In vitro, Ginsenoside Rg3 has strong
inhibition on the infiltration of mouse ascites hepato-
ma, melanoma B16FE7 cells, human small cell lung
cancer (OC-10), and human pancreatic carcinoma. In
contrast, the anti-infiltration effects of homolog ginsen-
osides Rb2 and 20(R)-Rg2 are weaker, and the ginsen-
osides Rh1, Rh2, 20(R)-Rh1, Rb1, Rc, and Re have no
anti-infiltration activities.19
Liu et al 20 found that LNCaP cells given Rg3 lost their
adhesion performance. The expressions of prostate-spe-
cific antigen, androgen receptor, 5α-reductase, and pro-
liferating cell nuclear antigen were inhibited. The de-
crease in the expression of the 5α-reductase gene effec-
tively stimulated the production of double-hydration
testicular hormone that promoted the proliferation of
prostate cells. This decrease inhibited the expression of
cell cycle genes such as proliferating cell nuclear anti-
gen gene, cell cycle protease gene, and therefore inhibit-
ed cell proliferation. By increasing the expressions of
cell cycle proteinase inhibitor genes p21 and p27, Rg3
blocked LNCaP cells in the G1 phase. By lowering the
inhibitor of apoptosis Bcl-2, and activating the apopto-
sis mechanism mediated by caspase 3, Rg3 could inhib-
it the growth of cells. The abnormal activation of PI3K/
Akt/mTOR signaling pathway caused the prolifera-
tion, differentiation, metastasis, and invasion of tumor
cells.
Ma et al 21 investigated the pro-apoptotic effect of gin-
senoside Rg3 on the PI3K/AKT pathways of endome-
trial carcinoma Hec-1-B cells. The results showed that
ginsenoside Rg3 had obvious inhibitory effects (P<
0.05) on the proliferation of Hec-1-B cells in vitro in a
dose- and time-dependent manner. The expression lev-
el and activity of cell telomerase PI3K and AKT de-
creased significantly. Therefore, Rg3 could inhibit cell
growth by inducing the apoptosis of human endometri-
al carcinoma Hec-1-B cells. One of the mechanisms by
which Rg3 induces apoptosis of human endometrial
carcinoma Hec-1-B cells in vitro is by inhibiting the ac-
tivity of PI3K and AKT.
Anti-tumor, angiogenesis, and pro-apoptotic effect of
benzyl compounds
Benzyl compounds are bioactive compounds found in
Chinese medicines Shancigu (Pseudobulbus Cremas-
trae), Shanyao (Rhizoma Dioscoreae Oppositae), Shixian-
tao (Pseudobulbus seu Herb Pholidotae Chinensis), Zhuy-
elan (Herba seu Rhizoma Arundinae Graminifoliae), Shi-
hu (Herba Dendrobii Nobilis), and Baiji (Rhizoma
Bletillae Striatae). Benzyl compounds have anti-tumor
and anti-angiogenesis activities.22,23
Xu et al 24 studied the antitumor activity of bryophyte
benzyl compound marchantin M and its mechanism of
action on prostate cancer cells. Marchantin M could in-
hibit the proliferation of human leukemia cells (K562),
human hepatoma cells (HepG2), human breast cancer
cells (MCF-7), and human prostate cancer cells (LN-
CaP, DU145, and PC-3). It had especially significant
inhibition on the proliferation of human prostate can-
cer cells PC-3, and weak inhibition on the prolifera-
tion of normal retinal pigment epithelial cell line
(hTERT-RPE1). Marchantin M blocked the PC-3 cells
in phase G0/G1. The PC-3 cell had an obvious sub-G1
peak along with changes in cycle-related proteins.
Moreover, 4', 6-diamidino-2-phenylindole showed
characteristic changes in nuclear apoptosis.
RESEARCH PROGRESS ON
SYNERGISTIC ANTI-TUMOR EFFECTS
OF COMPOUNDS INTCM
Effect of quercetin combined with ligustrazine on
growth of mouse Lewis lung cancer
Quercetin in vitro experiments confirmed that querce-
tin has inhibitory effects on leukemia, prostate cancer,
breast cancer, liver cancer, lung cancer, and colon cancer.
Fu et al 25 studied the influence of quercetin and ligust-
razine on mouse Lewis lung carcinoma growth. They
tested the expression levels of tumor tissue microvascu-
lar density, vascular endothelial growth factor (VEGF),
and PCNA with semi-quantitative immunohistochem-
istry, and tumor cell apoptosis index with in situ apop-
tosis terminal-deoxynucleoitidyl transferase mediated
nick end labeling. They replicated the model with
C57BL mice with transplanted Lewis lung carcinoma
cells, and all drug groups had inhibitory effects on
transplanted tumor growth. However, the combination
group had more obvious effects on tumor inhibition.
The tumor growth in the control group was significant-
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ly greater than that of the drug group, and the combi-
nation group had the slowest tumor growth. Cancer
cells in the drug groups had degeneration to different
degrees and obvious necrosis according to histopatho-
logical observation. In the quercetin and quercetin+li-
gustrazine groups, the vasculature in the mesenchyma
was obviously decreased. In the quercetin, ligustrazine,
and quercetin + ligustrazine groups, the growth of tu-
mor cells was significantly inhibited, with inhibition
rates of 39.87% , 35.45% , and 54.58% , respectively.
The inhibition rate of the quercetin+ligustrazine group
was significant higher than that of the single drug
groups (P<0.05).
Effect of platycodin D combined with ophiopogonin,
Cnidium lactones, and zedoary on the proliferation
and invasion of MDA-MB-231 breast cancer cells
Han et al 26 studied the effect of platycodin D with
ophiopogonin, platycodin D with Cnidium lactones,
and platycodin D with Rhizoma Zedoariae, on the pro-
liferation and invasion of 4T1 and MDA-MB-231
breast cancer cells. They found that the inhibitory ef-
fect of the platycodin D+ophiopogonin or platycodin
D+Cnidium lactones groups on the invasion of 4T1
cells was significantly superior to that of the platycodin
D + zedoary group and that of each component used
alone (P<0.05 or P<0.01). In addition, the inhibitory
effect of the platycodin D+zedoary group or platycodin
D + Cnidium lactones group on the invasion of
MDA-MB-231 cells was significantly superior to that
of the platycodin D + ophiopogonin group (P<0.01).
Therefore, the combination of platycodin D with oth-
er active ingredients in TCM could significantly inhib-
it the invasion and proliferation breast cancer 4T1 and
MDA-MB-231. As for the inhibitory effect on the pro-
liferation and invasion, different combinations had dif-
ferent performances.
Synergistic effect of ophiopogonin, ophiopogonone,
and ginsenosides on anti-malignant tumors
Shenmai injection (SM) is produced with equivalent
Renshen (Radix Ginseng) and Maidong (Radix Ophio-
pogonis Japonici). After observing the inhibition rate of
SM on human liver cancer SMMC-7721 cells in vitro,
Ye et al 27 found that at concentrations of 50-250 μL/
mL, the tumor cell proliferation inhibition rate was
9.0%-83.1% (P<0.01), in a dose-dependent relation-
ship. The apoptosis index of SMMC-7721 tumor cells
increased to 10.91% at a final concentration 200 μL/
mL, significantly superior to the 7.57% of the control
group. The cell cycle was blocked in the G0/G1 phase
and the cells number in G0 and G1 phases increased,
while the cell fraction in S and G2/M phase decreased
significantly. All these indicate that SM could reduce
the synthesis and mitosis of cell DNA, and has signifi-
cant inhibitory and pro-apoptotic effects on the prolif-
eration of human hepatoma SMMC-7721 cells.
Using human colorectal cancer cells injected into nude
mice, and immunohistochemistry, Ma et al 28 found
that SM could reduce the cancer tumor MVD, and
lower the expression of vascular endothelial growth fac-
tor VEGF. However, it had no affect on thrombin-sen-
sitive protein 1.
Inhibitory effect of honokiol combined with
artemisinin on human lung adenocarcinoma
SPC-A-1 cells
Honokiol is a biphenyl phenolic compound isolated
from Magnolia officinalis bark and has several pharma-
cological activities including tumor inhibitory effects.
Recent study has confirmed that honokiol can induce
apoptosis in many tumor cells.29
Wang et al 30 showed that honokiol and artemisinin
had synergetic inhibitory effects on lung adenocarcino-
ma SPC-A-1 cell growth. Honokiol could inhibit
SPC-A-1 cell proliferation in a dose-dependent man-
ner, with an IC50 of 8.20 μg/m, with no obvious inhibi-
tion on SPC-A-1 cell growth. The inhibitory effect of
honokiol combined with artemisinin on SPC-A-1 cells
proliferation was superior to that of the single drug
groups. Jin's formula was used to analyze the effect of
the drug combination and found Q>1.15.
Synergistic treatment mechanism of tetra-arsenic
tetra-sulfide, indirubin, and tanshinoneⅡ
Acute promyelocytic leukemia (APL) is an M3 type of
acute myeloid leukemia. Patients with APL accumulate
many immature promyelocytes in the bone marrow
and have severe bleeding. Two chromosome transloca-
tions cause the appearance of a new fusion gene
PML-RARα at the joint point of break and exchange.
This fusion gene encodes a fusion protein, and can in-
duce a series of gene expression as a nuclear receptor,
which ultimately leads to uncontrolled cell growth. Ar-
senic trioxide (ATO) is a useful drug for the treatment
of APL because its target is the PML-RARα fusion pro-
tein. ATO can degrade the oncoprotein leading to can-
cer apoptosis.31 APL is the first human malignant tu-
mor to be specifically treated at its molecular cause.
Chen et al 32 researched tetra-arsenic tetra-sulfide-tan-
shinone IIA-indirubin compound (ATI) preparations
in TCM and their preparation methods and applica-
tion in the preparation of antineoplastic drugs. RIF
compound preparations include tetra-arsenic tetra-sul-
fide (A), indirubin (I), and tanshinone Ⅱ A (T).
Among the ingredients, A is the main component of re-
algar, I is the active ingredient of natural indigo, and T
is the active ingredient of Salvia miltiorrhiza. As with
arsenic trioxide, tetra-arsenic tetra-sulfide (A) can also
induce the ubiquitination of the PML-RARα fusion
protein and the transportation to the nuclear reticu-
lum, and can be degraded by the soluble protein.33 I or
T used alone do not have this function. However, to-
gether with A, T and I can promote the ubiquitination
of PML-RARα and speed up its degradation. ATI has
the most significant degradation effect on cancer pro-
103
JTCM |www. journaltcm. com February 15, 2014 |Volume 34 | Issue 1 |
Zhou J et al. / Review
tein PML-RARα. Therefore, it can significantly extend
the median survival rate of mice with APL. ATI can in-
duce the differentiation of APL cells in vitro, and en-
hance the redifferentiation adjustment factor activity of
bone marrow cells. Cells need the CDK protein to
move from the G1 phase to the S phase. However, I is
an effective CDK inhibitor. Therefore, ATI has a
strong effect on blocking cells in the G1 phase. P27 is a
protein that can inhibit CDK, which is produced by
the cells themselves. By lowering CDK2, reducing
phospho-histone H1, and up-regulating P27 and
P27Rb, ATI can inhibit cell progression from G1 to S,
and thereby inhibit tumor cell proliferation.34
These results are consistent with traditional "monarch
and minister and assistant and guide" theory in TCM,
which provides a theoretical framework to understand
the mechanism of ATI treating APL, and helps TCM
practitioners understand the treatment mechanism of
other ancient compounds.
RESEARCH PROSPECTS INTCM
The biggest advantage of treating tumors with Chinese
medicines is that they can have a multiple sites and tar-
gets. This is why Chinese medicine has clinical effects
but multiples effects are obstacles to their populariza-
tion, internationalization, and modernization.35 One
Chinese medicine compound is made up of thousands
of compounds. Some Chinese medicines do not even
have molecular targets, so their mechanisms and effects
are uncertain. In contrast, Western Medicine is homog-
enous and drug factors can be identified, which pro-
vides quantifiable parameters for scientific research.
However, homogenous drug targets can only control or
relieve some symptoms. It is difficult to completely
cure complex diseases, such as cancer with one drug.
Chinese medicine takes into account the difference be-
tween individuals and the relationship between hu-
mans and the environment. The accumulation of
TCM knowledge provides the conditions for further
developing systems biology and integration with mod-
ern medicine.36
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